A further validation of subareolar injection technique for breast sentinel lymph node biopsy

Annals of Surgical Oncology

Volumn 13, Issue 5, 2006, Pages 701-707

  D'Eredita, Giovanni ^a   Giardina, Carmela ^a   Guerrieri, Angela Maria ^b   Berardi, Tommaso ^a  

^a UNIVERSITY OF BARI   (Italy)

^b POLICLINICO   (Italy)

Author keywords

Breast cancer; Lymphatic mapping; Sentinel lymph node biopsy; Subareolar injection

Indexed keywords

DYE; NANOCOL; NANOCOLL TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST AREOLA; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FEASIBILITY STUDY; HUMAN; HUMAN TISSUE; INJECTION; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; LYMPH NODE DISSECTION; LYMPHATIC DRAINAGE; MAJOR CLINICAL STUDY; MULTIPLE CANCER; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TOPOGRAPHY; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; COLORING AGENTS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; INJECTIONS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NIPPLES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 33645856790     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/ASO.2006.04.027     Document Type: Article

References (32)

1. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220:391-401.
2. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276:1818-22.
3. Linehan DC, Hill AD, Akhrust T, et al. Intradermal radio-colloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol 1999; 6:450-4.
4. Cox CE. Lymphatic mapping in breast cancer: combination technique. Ann Surg Oncol 2001; 8(9 Suppl):67-70.
5. Crossin JA, Johnson AC, Stewart PB, Turner WW Jr. Gamma-probe-guided resection of the sentinel lymph node in breast cancer. Am Surg 1998; 64:666-8.
6. Krag DN, Weaver D, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2:335-40.
7. McMasters KM, Wong SL, Martin RC, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multi-institutional study. Ann Surg 2001; 233:676-87.
8. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349:1864-7.
9. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 227:645-51.
10. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet 1997; 349:1668-9.
11. Borgstein PJ, Meijer S, Pijpers RJ, van Diest PJ. Functional lymphatic anatomy for sentinel node biopsy in breast cancer. Ann Surg 2000; 232:81-9.
12. Sappey MPC. Traité d'Anatomie Descriptive, Second Edition. Paris: Labé, 1888.
13. Gray J. The relation of the lymphatic vessels to the spread of cancer. Br J Cancer 1939; 26:462-95.
14. Kern KA. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. J Am Coll Surg 1999; 189:539-45.
15. Klimberg VS, Rubio IT, Henri R, Cowan C, Colvert M, Korourian S. Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg 1999; 229:860-5.
16. Smith LF, Cross MJ, Klimberg VS. Subareolar injection is a better technique for sentinel lymph node biopsy. Am J Surg 2000; 180:434-7.
17. D'Eredita G, Ferrarese F, Cecere V, Massa ST, De Carne F, Fabiano G. Subareolar injection may be more accurate than other techniques for sentinel lymph node biopsy in breast cancer. Ann Surg Oncol 2003; 10:942-7.
18. Hsu SM, Raine L, Fauger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP procedures). J Histochem Cytochem 1981; 29:577-80.
19. Cody HS, Hill ADK, Tran KN, et al. Credentialing for breast lymphatic mapping: how many cases are enough? Ann Surg 1999; 229:723-8.
20. Kern KA, Rosenberg RJ. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid. J Am Coll Surg 2000; 191:479-89.
21. Donahue EJ. Sentinel node imaging and biopsy in breast cancer patients. Am J Surg 2001; 182:426-8.
22. Beitsch PD, Clifford E, Whitworth P, Abarca A. Improved lymphatic mapping technique for breast cancer. Breast J 2001; 7:219-23.
23. Tuttle TM, Colbert M, Christensen R, et al. Subareolar injection of 99m-Tc facilitates sentinel lymph node identification. Ann Surg Oncol 2002; 9:77-81.
24. Bauer TW, Spitz FR, Callans LS, et al. Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer. Ann Surg Oncol 2002; 9:169-76.
25. Kern KA. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid. J Am Coll Surg 2002; 195:467-75.
26. Pelosi E, Baiocco C, Ala A, et al. Lymphatic mapping in early stage breast cancer: comparison between periareolar and subdermal injection. Nucl Med Commun 2003; 24:519-23.
27. Chagpar A, Martin RC III, Chao C, et al. Validation of subareolar and peritumoral injection techniques for breast sentinel lymph node biopsy. Arch Surg 2004; 139:614-20.
28. Mertz L, Mathelin C, Marin C, et al. Subareolar injection of 99m-Tc sulfur colloid for sentinel node identification in multifocal invasive breast cancer. Bull Cancer 1999; 86:939-45.
29. Schrenk P, Wayand W. Sentinel-node biopsy in axillary lymphnode staging for patients with multicentric breast cancer. Lancet 2001; 357:122.
30. Ozmen V, Muslumanoglu M, Cobioglu N, et al. Increased false negative rate in sentinel lymph node biopsies in patients with multifocal breast cancer. Breast Cancer Res Treat 2002; 76:237-44.
31. Kumar R, Jana S, Heiba SI, et al. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable or nonpalpable breast cancer. J Nucl Med 2003; 44:7-10.
32. Layeeque R, Tilman RH, Korourian S, Kass R, Klimberg S. Subareolar sentinel node biopsy for multiple breast cancers. Am J Surg 2003; 186:730-6.